AN AUTOPSY BASED STUDY OF MATERNAL DEATHS

Dr. M. Sakthimani, Dr. T. Jeyasingh, Dr. S. Peranantham

Abstract


In 2015, approximately 830 women died worldwide every day due to complications of pregnancy or childbirth. Based on the world health statistics (WHS) 2016 the MMR (Maternal Mortality Ratio) of India is 174/ 100,000 live births[1]. Maternal Mortality Ratio has declined since 1990 still our MMR is higher than the developed countries. This study was conducted in the Department of Forensic Medicine, Government Coimbatore medical college and hospital, Coimbatore from January 2008 to December 2017. A total number of 25 medico-legal cases of maternal deaths were brought for postmortem during the study period.  Postpartum haemorrhage remains leading cause of death (30%) followed by Amniotic Fluid Embolism (AFE) causes (20%), indirect (20%), sepsis (12%), undetermined (10%)and Thrombo-Embolism(8%). The clinical manifestation of AFE resembles both embolism and anaphylaxis. Encouraging hospital autopsy with histopathology along with immune histochemistry and microbiology examination in all maternal deaths will help in invention of novel treatment modalities.


Keywords


Maternal Mortality Ratio; Postpartum hemorrhage; Amniotic fluid embolism; Histopathology.

Full Text:

PDF

References


World Health Organization, Regional Office for South East Asia. Maternal Health in South East Asia Region 2015. New Delhi, India: WHO; 2015.

World Health Statistics 2018. Geneva: World Health Organization;2018 (http://www.who.int/gho/publications/world_health_statistics/2018/en/)

Dr. Zachariah Thomas ,DIRECT CAUSES OF MATERNAL DEATH AN AUTOPSY STUDYInt. J. Adv. Res. 5(7), 2278-2285.

R. V. Bardale, MD, **P. G. Dixit, MD (Path), MD (FMT),Pregnancy-related deaths: A Three-year retrospective study,J Indian Acad Forensic Med, 32(1)ISSN 0971-0973

GBD 2013 Mortality causes of death collaborators (January 2015). “global, regional, and national age-sex specific all cause and cause-specific mortality for 240 causes of death, 1990-2013: a systemic analysis for the Global Burden of disease study 2013”. Lancet. 385 (9963): 117-71. Doi:10.1016/S0140-6736(14)61682-2. PMC 4310604. PMID 25530442.

Patel A., Shukla D., Hazra M. retained placenta: the third stage threat (12 years study). J ObstetGynecol India 1991; 41: 606-10.

KalurJS., Martin JN. Jr., Kirchner KA., Morrison JC. Postpartum pre-eclamsia-induced shock and death: A report of three cases. Am J ObstetGynecol 1991; 165: 1362-8.

Attwood HD. Fatal pulmonary embolism by amniotic fluid. J Clin Pathol 1956; 9: 38–46.

Courtney LD. Amniotic fluid embolism. ObstetGynecolSurv 1974; 29: 169–177.

Lau G. Amniotic fluid embolisom a cause of sudden maternal death. Med Sci Law 1994; 34: 213–220.

Marcus BJ, Collins KA, Harley RA. Ancillary studies in amnioticfluid embolism: a case report and review of the literature.Am J Forensic Med Pathol 2005; 26: 92–95.

HikijiW, TamuraN, Shigeta A, KanayamaN, Fukunaga T. Fatalamniotic fluid embolism with typical pathohistological, histochemicaland clinical features. Forensic SciInt 2013; 226:e16–e19.

Furuta N, Yaguchi C, Itoh H et al. Immunohistochemical detectionof meconium in the fetal membrane, placenta and umbilicalcord. Placenta 2012; 33: 24–30.

Matsuda Y, KamitomoM. Amniotic fluid embolism: a comparisonbetween patients who survived and those who died. J IntMed Res 2009; 37: 1515–1521.

Kobayashi T. Obstetrical disseminated intravascular coagulationscore. J ObstetGynaecol Res 2014; 40: 1500–1506.

Kobayashi H. The entry of fetal and amniotic fluid components into the uterine vessel circulation leads to sterile inflammatory processes during parturition. Front Immunol 2012; 3: 321.

Tamura N, Kimura S, Farhana M et al. C1 esterase inhibitor activityin amniotic fluid embolism. Crit Care Med 2014; 42:1392–1396.

Todo Y, Tamura N, Itoh H, Ikeda T, Kanayama N. Therapeuticapplication of C1 esterase inhibitor concentrate for clinical amnioticfluid embolism: a case report. Clin Case Rep 2015; 3:673–675.

Ogihara T, Morimoto K, Kaneko Y. Continuous hemodiafiltration for potential amniotic fluid embolism: dramatic responses observed during a 10-year period report of three cases. Ther Apher Dial 2012; 16: 195–197.

WekslerN,Ovadia L, StavA, Ribac L, IuchtmanM. Continuous arteriovenous hemofiltration in the treatment of amniotic fluid embolism. Int J Obstet Anesth 1994; 3: 92–96.

NaoakiTamura ,MustariFarhana , TomoakiOda, Hiroaki Itoh and NaohiroKanayama, Amniotic fluid embolism: Pathophysiology from the perspective of pathology, J. Obstet. Gynaecol. Res. Vol. 43, No. 4: 627–632, April 2017.doi:10.1111/jog.13284.

NaohiroKanayama, Junko Inori, HatsueIshibashi-Ueda, Makoto Takeuchi, Masahiro Nakayama, Satoshi Kimura, Yoshio Matsuda, Jun Yoshimatsu and Tomoaki Ikeda, Maternal death analysis from the Japanese autopsy registry for recent 16 years: significance of amniotic fluid embolism, J. Obstet. Gynaecol. Res. Vol. 37, No. 1: 58–63, January 2011,doi:10.1111/j.1447-0756.2010.01319.x.


Refbacks

  • There are currently no refbacks.